Botulinum toxin for treatment of glandular hypersecretory disorders.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Department of Plastic and Reconstructive Surgery, Cork University Hospital, Cork,, Ireland.Issue Date
2012-02-03T15:07:03ZMeSH
AdolescentAged
Aged, 80 and over
Botulinum Toxins, Type A/*therapeutic use
Female
Humans
Hyperhidrosis/drug therapy
Infant
Lacrimal Apparatus Diseases/drug therapy
Male
Middle Aged
Neurotoxins/*therapeutic use
Rhinitis, Vasomotor/drug therapy
Salivary Gland Diseases/*drug therapy
Sialadenitis/drug therapy
Sialorrhea/drug therapy
Sweat Gland Diseases/*drug therapy
Sweating, Gustatory/drug therapy
Treatment Outcome
Metadata
Show full item recordCitation
J Plast Reconstr Aesthet Surg. 2008 Sep;61(9):1024-8. Epub 2008 Jul 10.Journal
Journal of plastic, reconstructive & aesthetic surgery : JPRASDOI
10.1016/j.bjps.2008.03.023PubMed ID
18619934Abstract
SUMMARY: The use of botulinum toxin to treat disorders of the salivary glands is increasing in popularity in recent years. Recent reports of the use of botulinum toxin in glandular hypersecretion suggest overall favourable results with minimal side-effects. However, few randomised clinical trials means that data are limited with respect to candidate suitability, treatment dosages, frequency and duration of treatment. We report a selection of such cases from our own department managed with botulinum toxin and review the current data on use of the toxin to treat salivary gland disorders such as Frey's syndrome, excessive salivation (sialorrhoea), focal and general hyperhidrosis, excessive lacrimation and chronic rhinitis.Language
engISSN
1878-0539 (Electronic)1748-6815 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1016/j.bjps.2008.03.023
Scopus Count
Collections
Related articles
- Botulinum toxin treatment of secretory disorders.
- Authors: Naumann M, Jost W
- Issue date: 2004 Mar
- Botulinum toxin therapy: functional silencing of salivary disorders.
- Authors: Lovato A, Restivo DA, Ottaviano G, Marioni G, Marchese-Ragona R
- Issue date: 2017 Apr
- Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
- Authors: Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R
- Issue date: 2004 Oct
- Clinical results in the management of Frey's syndrome with injections of Botulinum toxin.
- Authors: Martos Díaz P, Bances del Castillo R, Mancha de la Plata M, Naval Gías L, Martínez Nieto C, Lee GY, Muñoz Guerra M
- Issue date: 2008 Apr 1
- Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
- Authors: Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D
- Issue date: 2013 Jun 1